CTR-FAPI PET Enables Precision Management of Medullary Thyroid CarcinomaZiren Kong, Shaoyan Liu, Yiming Zhu et al.|Cancer Discovery|2024Cited by 23
Covalent FAPI PET enables accurate management of medullary thyroid carcinoma: A prospective single-arm comparative clinical trial.Ziren Kong, Shaoyan Liu, Li Zhu et al.|Journal of Clinical Oncology|2024Cited by 1
Notification to AttendingPhysician from CTR-FAPI PET Enables Precision Management of Medullary Thyroid CarcinomaZiren Kong, Shaoyan Liu, Zhu Li et al.|Unknown|2025Cited by 0
Supplementary Figure 3 from CTR-FAPI PET Enables Precision Management of Medullary Thyroid CarcinomaZiren Kong, Shaoyan Liu, Zhu Li et al.|Unknown|2025Cited by 0
Supplementary Table 14 from CTR-FAPI PET Enables Precision Management of Medullary Thyroid CarcinomaZiren Kong, Shaoyan Liu, Li Zhu et al.|Unknown|2025Cited by 0